Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion type Assertion NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_head.
- NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion description "[We found hypermethylation of HS3ST2 in 93% of cancer tissues and 70% of cytology specimens interpreted as CIN3; hypermethylation of CDH1 was found in 89% of cancers and 26% of CIN3 cytology specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_provenance.
- NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion evidence source_evidence_literature NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_provenance.
- NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion SIO_000772 17894941 NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_provenance.
- NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion wasDerivedFrom befree-20140225 NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_provenance.
- NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_assertion wasGeneratedBy ECO_0000203 NP658303.RA9GPg2H_MajZ7o3nQUJGjRmSW0f8IHjt_29wyM6j1pjA130_provenance.